Hitachi to Provide CNAO with Proton Therapy System
Tokyo, December 6, 2019 --- Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced that it has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.
In comprehensive public tender process, Hitachi has been selected to provide proton therapy system with latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.
MADISON, Wis. U.S., 27 July 2022
Hitachi Chosen as Proton Therapy Provider for UW Health Eastpark Medical Center
Read more Select category Healthcare Manufacturing Tokyo, Japan, 6 January 2021
Olympus and Hitachi Announce Long-Term Business Alliance
Read more Select category Corporate News Healthcare Research & Development